Active Biotech AB (publ) is a Sweden-based Company, which develops pharmaceutical products within medical areas where the immune defense is important, including cancer and inflammatory diseases. The project portfolio comprises both small, orally active immunomodulatory molecules and antibody-based immunotherapy.

Employees

Sector

Biotechnology & Medical Research

Calendar

20/08 Earnings release - Q2 2026

More about the company

Market Cap	138M 14.54M 12.6M 11.79M 10.76M 20.25M 1.39B 20.6M 54.19M 695M 54.61M 53.42M 2.33B	P/E 2026 *	-	P/E 2027 *	-
Enterprise Value	138M 14.54M 12.6M 11.79M 10.76M 20.25M 1.39B 20.6M 54.19M 695M 54.61M 53.42M 2.33B	EV / Sales 2026 *	-	EV / Sales 2027 *	-
Free-Float	81.52%	Yield 2026 *	-	Yield 2027 *	-

25/07	Active Biotech Doses First Patient in Amended Ho172 Clinical Study of Tasquinimod in Myelofibrosis	CI
24/07	Active Biotech Doses First Patient in Amended Tasquinimod Myelofibrosis Trial	MT
24/07	Active Biotech doses first patient in updated tasquinimod study	FW
07/06	Certain Shares of Active Biotech AB are subject to a Lock-Up Agreement Ending on 7-JUN-2026.	CI
01/04	Active Biotech AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2025	CI

24/07	First patient dosed in the amended HO172 clinical study of tasquinimod in myelofibrosis	AQ
30/06	Number of shares and votes in Active Biotech	AQ

Manager	Title	Age	Since
Helén Tuvesson CEO	Chief Executive Officer	64	01/07/2017
Hans Kolam DFI	Director of Finance/CFO	75	01/01/2000
Erik Vahtola CTO	Chief Tech/Sci/R&D Officer	-	01/01/2022

Director	Title	Age	Since
Karl Peter Thelin BRD	Director/Board Member	70	07/04/2011
Michael Shalmi CHM	Chairman	61	23/05/2019
Uli Alf Hacksell BRD	Director/Board Member	76	23/05/2019

Active Biotech AB Stock Other OTC

Stocks

Biotechnology & Medical Research

Valuation: Active Biotech AB

Latest news : Active Biotech AB

Press Releases: Active Biotech AB

Managers and Directors: Active Biotech AB

Bio Therapeutic Drugs

Financials

Company Profile

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ACTIVE BIOTECH AB	-.--%	-.--%	-	-	15M
WUXI APPTEC CO., LTD.	-0.70%	+24.68%	+76.72%	+103.05%	70.85B
ARGENX SE	-2.35%	+3.71%	+31.77%	+63.89%	55.41B
INSMED INCORPORATED	-1.62%	+34.66%	+21.01%	+483.49%	29.43B
WUXI BIOLOGICS (CAYMAN) INC.	-0.30%	+18.51%	+56.61%	+4.86%	24.12B
BIONTECH SE	0.00%	+0.60%	-16.89%	-12.00%	23.31B
GENMAB A/S	+0.05%	+7.96%	+44.21%	-22.57%	18.37B
PHARMAESSENTIA CORPORATION	+9.77%	+25.32%	+252.40%	+442.16%	16.99B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	0.00%	+10.84%	+31.14%	+628.97%	16.1B
EXELIXIS, INC.	-3.08%	-6.77%	+36.08%	+142.70%	13.12B
Average	+0.18%	+390.71%	+59.23%	+203.84%	29.75B
Weighted average by Cap.	-0.40%	+349.16%	+55.52%	+164.38%

	2026 *	2027 *
Net sales	-	-
Net income	-33.2M -3.49M -3.02M -2.83M -2.58M -4.86M -333M -4.94M -13M -167M -13.1M -12.82M -560M	18.2M 1.91M 1.66M 1.55M 1.42M 2.66M 183M 2.71M 7.13M 91.36M 7.18M 7.03M 307M
Net Debt	-	-